{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:30:02Z","timestamp":1790166602922,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T00:00:00Z","timestamp":1241568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,27]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Interleukin (IL)-22 production triggered by innate immune mechanisms has been identified as key to efficient intestinal anti-bacterial host defence and preservation of homeostasis. We hypothesized that glucocorticoid therapy may impair IL-22 expression, which should promote intestinal epithelial damage with the potential of subsequent bacterial translocation. High-dose corticosteroid therapy in Crohn\u2019s disease has been associated with an increased rate of abscess formation and ultimately with a higher risk of developing postoperative infectious complications, including abdominal sepsis. Thus, we sought to investigate effects of the prototypic glucocorticoid dexamethasone on IL-22 production in the context of bacterial infection. Enhanced IL-22 plasma levels were detectable in rat sepsis. Moreover, heat-inactivated Staphylococcus epidermidis, used as a prototypic activator of innate immunity, induced robust production of IL-22 by human peripheral blood mononuclear cells (PBMC). Here, we report for the first time that dexamethasone mediates remarkable suppression of IL-22 as detected in S. epidermidis-activated PBMC and rat sepsis, respectively. The data presented herein suggest that insufficient IL-22 function may contribute to impaired intestinal host defence in the context of corticosteroid therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2009.03969.x","type":"journal-article","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T05:01:05Z","timestamp":1241586065000},"page":"370-376","source":"Crossref","is-referenced-by-count":35,"title":["Dexamethasone suppresses interleukin-22 associated with bacterial infection\n                    <i>in vitro<\/i>\n                    and\n                    <i>in vivo<\/i>"],"prefix":"10.1093","volume":"157","author":[{"given":"E","family":"Ziesch\u00e9","sequence":"first","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Scheiermann","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Hospital of the Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bachmann","sequence":"additional","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C D","family":"Sadik","sequence":"additional","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hofstetter","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Goethe University Frankfurt, Frankfurt am Main"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zwissler","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Hospital of the Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pfeilschifter","sequence":"additional","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"M\u00fchl","sequence":"additional","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,5,6]]},"reference":[{"key":"2022011117464036000_b1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","article-title":"Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells","volume":"17","author":"Wolk","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022011117464036000_b2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"key":"2022011117464036000_b3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"2022011117464036000_b4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/eji.200838331","article-title":"Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells","volume":"38","author":"Gu","year":"2008","journal-title":"Eur J Immunol"},{"key":"2022011117464036000_b5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"key":"2022011117464036000_b6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"2022011117464036000_b7","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022011117464036000_b8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2022011117464036000_b9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"2022011117464036000_b10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"2022011117464036000_b11","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"2022011117464036000_b12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity"},{"key":"2022011117464036000_b13","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation","volume":"118","author":"Ma","year":"2008","journal-title":"J Clin Invest"},{"key":"2022011117464036000_b14","doi-asserted-by":"crossref","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","article-title":"IL-22 is increased in active Crohn\u2019s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration","volume":"290","author":"Brand","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022011117464036000_b15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"2022011117464036000_b16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"2022011117464036000_b17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1286-4579(03)00096-0","article-title":"Inducible nitric oxide synthase and control of intracellular bacterial pathogens","volume":"5","author":"Chakravortty","year":"2003","journal-title":"Microbes Infect"},{"key":"2022011117464036000_b18","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1074\/jbc.M611040200","article-title":"The interleukin-22\/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells","volume":"282","author":"Ziesch\u00e9","year":"2007","journal-title":"J Biol Chem"},{"key":"2022011117464036000_b19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2249.2001.01656.x","article-title":"Dexamethasone impairs pulmonary defence against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice","volume":"126","author":"Satoh","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2022011117464036000_b20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood\u2013brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"2022011117464036000_b21","first-page":"1273","article-title":"Warner-Lambert\/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier","volume":"137","author":"Madara","year":"1990","journal-title":"Am J Pathol"},{"key":"2022011117464036000_b22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1542-3565(05)00759-7","article-title":"Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn\u2019s disease","volume":"3","author":"Agrawal","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022011117464036000_b23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","article-title":"Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients","volume":"125","author":"Aberra","year":"2003","journal-title":"Gastroenterology"},{"key":"2022011117464036000_b24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/BF02236563","article-title":"Risk factors for intra-abdominal sepsis after surgery in Crohn\u2019s disease","volume":"43","author":"Yamamoto","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"2022011117464036000_b25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jss.2008.02.032","article-title":"Cecal ligation and incision: an acute onset model of severe sepsis in rats","volume":"151","author":"Scheiermann","year":"2009","journal-title":"J Surg Res"},{"key":"2022011117464036000_b26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"2022011117464036000_b27","first-page":"2834","article-title":"Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor","volume":"84","author":"Franchimont","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011117464036000_b28","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1128\/IAI.01564-06","article-title":"Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis","volume":"75","author":"Weber","year":"2007","journal-title":"Infect Immun"},{"key":"2022011117464036000_b29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1074-7613(03)00206-1","article-title":"Regulation by C5a of neutrophil activation during sepsis","volume":"19","author":"Riedemann","year":"2003","journal-title":"Immunity"},{"key":"2022011117464036000_b30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4049\/jimmunol.177.2.1306","article-title":"Divergent signaling pathways in phagocytic cells during sepsis","volume":"177","author":"Guo","year":"2006","journal-title":"J Immunol"},{"key":"2022011117464036000_b31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/01.shk.0000185795.96964.71","article-title":"Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis","volume":"24","author":"Singleton","year":"2005","journal-title":"Shock"},{"key":"2022011117464036000_b32","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","article-title":"TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice","volume":"181","author":"McKinley","year":"2008","journal-title":"J Immunol"},{"key":"2022011117464036000_b33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2036.2006.03174.x","article-title":"Review article: bacterial translocation in the critically ill \u2013 evidence and methods of prevention","volume":"25","author":"Gatt","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2009.03969.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/157\/3\/370\/42097734\/j.1365-2249.2009.03969.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/157\/3\/370\/42097734\/j.1365-2249.2009.03969.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T14:38:26Z","timestamp":1641911906000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/157\/3\/370\/6428795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,6]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,5,6]]},"published-print":{"date-parts":[[2009,7,27]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03969.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164454.626209","asserted-by":"object"}]},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,9]]},"published":{"date-parts":[[2009,5,6]]}}}